Active form of prodrug: Melphalan [DR:D00369]
Treatment of multiple myeloma
Target
DNA
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA10 Melphalan flufenamide
D11870 Melphalan flufenamide hydrochloride (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11870
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11870
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11870
Other DBs
CAS:
380449-54-7
LinkDB
KCF data
ATOM 34
1 C8y C 24.0748 -17.2863
2 N1c N 25.2645 -17.9861
3 C8x C 22.8151 -17.9861
4 C8x C 24.0748 -15.8866
5 C1b C 25.2645 -19.3858
6 C1b C 26.4543 -17.2863
7 C8x C 21.6253 -17.2863
8 C8x C 22.8151 -15.1867
9 C8y C 21.6253 -15.8866
10 C1b C 20.4356 -15.1867
11 C1c C 19.1758 -15.8866
12 C5a C 17.9861 -15.1867
13 N1a N 19.1758 -17.2863
14 N1b N 16.7964 -15.8866
15 O5a O 17.9861 -13.8570
16 C1b C 26.4543 -15.8866
17 X Cl 27.7140 -15.1867
18 C1b C 24.0048 -20.0856
19 X Cl 24.0048 -21.4853
20 C1c C 15.6066 -15.1867
21 C1b C 14.4169 -15.8866
22 C7a C 15.6066 -13.7870
23 O6a O 16.8663 -13.1571
24 O7a O 14.4169 -13.0172
25 C8y C 13.1571 -15.1867
26 C1b C 14.4169 -11.6175
27 C1a C 13.2271 -10.9176
28 C8x C 13.1571 -13.7870
29 C8x C 11.9674 -13.0872
30 C8y C 10.7777 -13.7870
31 C8x C 10.7777 -15.2567
32 C8x C 11.9674 -15.8866
33 X F 9.5179 -13.0872
34 X Cl 24.5000 -11.6200
BOND 34
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 7 9 2
9 9 10 1
10 10 11 1
11 11 12 1
12 11 13 1 #Down
13 12 14 1
14 12 15 2
15 8 9 1
16 6 16 1
17 16 17 1
18 5 18 1
19 18 19 1
20 14 20 1
21 20 21 1
22 20 22 1 #Up
23 22 23 2
24 22 24 1
25 21 25 1
26 24 26 1
27 26 27 1
28 25 28 2
29 28 29 1
30 29 30 2
31 30 31 1
32 31 32 2
33 25 32 1
34 30 33 1
